We’re honored to announce PharmSky’s Chief Scientific Consultant Ben Boyd has been elevated by American Association of Pharmaceutical Scientists (AAPS) to Fellow Status.
Class of 2023 AAPS Fellows who were selected based on well-defined criteria for outstanding scientific accomplishments, significant and sustained impact in the pharmaceutical sciences, and exceptional service to the AAPS community.
The new Fellows will be formally inducted before the membership at PharmSci360 on Sunday, October 22.
Ben Boyd is recognized as an established scholar at the intersection of drug delivery and colloid science, focusing on lipid and lipid self-assembly and the development of new methods to study these topics. He has published more than 300 papers, attracting more than 16,000 citations, and is a past President and Fellow of the Controlled Release Society as well as past President of the Australasian Colloid and Interface Society. He currently serves as co-editor of Journal of Colloid and Interface Science, was Editor for Asia for Drug Delivery and Translational Research and sits on numerous editorial advisory boards. Dr. Boyd has mentored 42 Ph.D. students. His research has attracted significant national and international funding, including multiple grants from the Bill and Melinda Gates Foundation, and prestigious fellowships from the Australian Research Council and the Novo Nordisk Foundation, the latter of which he is currently undertaking at the University of Copenhagen.
